English
简体中文
Total: £ 56.28
2025-10-16 | Pages: 119 | Tables: 120
The global Filgotinib Tablets market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce ...
2025-10-16 | Pages: 124 | Tables: 117
The global Ruxolitinib Drugs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce t...
2025-10-16 | Pages: 136 | Tables: 135
The global rh-EGF Topical Solution market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies intro...
2025-10-16 | Pages: 139 | Tables: 139
The global Ziprasidone Mesylate for Injection market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff pol...
2025-10-16 | Pages: 167 | Tables: 156
The global Ziprasidone Drugs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce t...
2025-10-16 | Pages: 123 | Tables: 114
The global L-glutamine Oral Powder market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies intro...
2025-10-16 | Pages: 139 | Tables: 132
The global Icatibant Acetate market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce t...
2025-10-16 | Pages: 110 | Tables: 126
The global Oral Complement Inhibitors market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies in...
2025-10-16 | Pages: 155 | Tables: 161
The global Complement Inhibitors market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introdu...
2025-10-16 | Pages: 128 | Tables: 113
The global Geographic Atrophy Drugs market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies intr...
2025-10-16 | Pages: 148 | Tables: 131
The global Drugs for PNH market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade...
2025-10-16 | Pages: 137 | Tables: 137
The global Treatment of PNH market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce tr...
2025-10-16 | Pages: 119 | Tables: 119
The global Complement C5 Recombinant Monoclonal Antibody market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S....
2025-10-16 | Pages: 160 | Tables: 147
The global Personalized Vitamin Supplements market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications.Personalized vitamin supplements ...
2025-10-16 | Pages: 132 | Tables: 149
The global Complement Protein C5 Inhibitors market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff polic...
